Research Progress on Concurrent Surgical Approaches in the Treatment of Benign Prostatic Hyperplasia (BPH)

Benign prostatic hyperplasia (BPH) is an age-related non-cancerous condition, affecting approximately 50% of men over the age of 50, with the prevalence rising to over 80% in men over 80 years old. Elevated prostate-specific antigen (PSA) levels are commonly indicative of prostate diseases such as BPH or prostate cancer. In patients with multiple comorbidities and a limited life expectancy, even if prostate cancer is diagnosed, they may not be candidates for radical surgery. Therefore, a treatment approach that can both diagnose and relieve lower urinary tract obstruction is needed. Performing prostate biopsy and surgical treatment concurrently allows for both diagnosis and therapy in a single procedure, reducing the risks and recovery time associated with multiple surgeries, while enhancing the patient’s treatment experience and satisfaction. This article aims to explore the efficacy and safety of concurrent prostate biopsy and 1470 nm laser surgery.